News

Industry News

View All » Industry News RSS Feed
Reyvow (Lasmiditan) Tablets Approved for Acute Migraine

Reyvow (Lasmiditan) Tablets Approved for Acute Migraine

The FDA has approved Reyvow (lasmiditan) tablets for the acute treatment of migraine with or without aura in adults. This drug is not indicated for the preventive treatment of migraine and can cause driving impairment, which is why Reyvow is pending controlled substance scheduling.

Read More »
FDA Approves First Lyrica Generics

FDA Approves First Lyrica Generics

The FDA has approved the first generic versions of Lyrica (pregabalin), granting approvals to a total of nine pharmaceutical companies for five different conditions, including the management of neuropathic pain associated with spinal cord injury.

Read More »